Companies / Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc.

Nasdaq: ELDNCIK 1404281IRVINE, CA

Financials · FY2016

Revenue$0
Net income$-45.62M
Total debt
Cash$6.80M
Diluted EPS$-0.52
Shares outstanding77.2M

Ownership

77.2M shares outstanding · as of May 7, 2026
0.03%Insiders
Ownership
Insiders0.03%25,725
10%+ / strategic4.70%3,625,824
Institutions54.28%41,894,205
Public float40.99%31,642,069

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all →
Insider% of sharesShares
Katkin KeithDirector
0.01%8,575
Hillson JanDirector
<0.01%3,430
Kirk AllanDirector
<0.01%3,430
Lee JuneDirector
<0.01%3,430
<0.01%3,430
<0.01%3,430

Institutional holders 101

View all →

Activity

InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 10, 2026Robinson James A. Jr.
Director
ExerciseCommon Stock$0+3K
3,430
<0.01% of shares
low
Jan 10, 2026Lee June
Director
ExerciseCommon Stock$0+3K
3,430
<0.01% of shares
low
Jan 10, 2026McBride John S.
Director
ExerciseCommon Stock$0+3K
3,430
<0.01% of shares
low
Jan 10, 2026Hillson Jan
Director
ExerciseCommon Stock$0+3K
3,430
<0.01% of shares
low
Jan 10, 2026Kirk Allan
Director
ExerciseCommon Stock$0+3K
3,430
<0.01% of shares
low
Jan 10, 2026Katkin Keith
Director
ExerciseCommon Stock$0+9K
8,575
0.01% of shares
low
Jan 10, 2026Robinson James A. Jr.
Director
ExerciseRestricted Stock Units-3K
-100.00%
0
0.00% of shares
low
Jan 10, 2026Lee June
Director
ExerciseRestricted Stock Units-3K
-100.00%
0
0.00% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Vanguard Group IncPassive13G/A0
RA Capital Management, L.P.Passive13G/A
BlackRock, Inc.Passive13G/A3,625,824
Coastlands Capital LPPassive13G/A

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ELDN28617K101